Biosensors International Group, Ltd. develops, manufactures and markets medical devices for interventional cardiology and critical care procedures. The Company's segments include Critical care, Interventional cardiology, Cardiac diagnostic, and Licensing and royalties revenue. It offers devices and solutions in therapeutic area, including cardiovascular, endovascular, critical care and cardiac imaging. In the cardiovascular area, the Company focuses on drug-eluting stents, drug coated stents and bare metal stents, as well as angioplasty catheters for the treatment of coronary artery disease. Its endovascular product portfolio includes stenting and ballooning solutions for superficial femoral artery, and below the knee interventions. Its critical care products include vascular catheters, pressure monitoring kits and blood pressure transducers. It offers D-SPECT, a nuclear cardiac imaging system. Its products include BioFreedom, BioMatrix Flex, Axxess, Chroma, Gazelle and BioStream.